Welcome to my website, where you'll feel right at home. I'm Sherif, and I've created this space just for you. Let's explore together!
Automated anti-D quantification in immunization and prophylaxis contexts with Cécile TOLY-NDOUR
Automated anti-D quantification in immunization and prophylaxis contexts with Cécile TOLY-NDOUR

Automated anti-D quantification in immunization and prophylaxis contexts with Cécile TOLY-NDOUR

Automated anti-D quantification in immunization and prophylaxis contexts with Cécile TOLY-NDOUR

BIORAD Transfusion Science Webinar

Antibody titration plays a crucial role in clinical settings, providing essential information about antibody concentrations. However, due to inherent imprecision, antibody titration has long been a challenge. The automation of this procedure represents a significant step toward standardization, improved accuracy, and complete traceability.

One prominent application of antibody titration is the administration of prophylactic anti-D to prevent anti-D alloimmunization during pregnancy, which has proven highly effective. However, during antibody screening, distinguishing weak immune anti-D from passive anti-D resulting from prophylactic administration is vital, as it holds significant clinical implications.

Join  in this enlightening webinar as Dr. Cécile TOLY-NDOUR, PharmD, PhD in Immunology, unveils the capabilities of automated anti-D microtitration on the IH-500 system. Dr. TOLY-NDOUR will demonstrate how this innovative approach easily distinguishes between passive and immune anti-D. Additionally, she will discuss the advantages of the automated gel anti-D titration method on the IH-500 system, its correlation with the reference tube method, and the value of gel titer scores in monitoring pregnancies complicated by anti-D alloimmunization.

Dr. Cécile TOLY-NDOUR is a highly experienced hospital practitioner at the laboratory of the French National Reference Center in Perinatal Hemobiology, located at the Saint Antoine Hospital (Assistance Publique des hôpitaux de Paris) in Paris. The center specializes in managing pregnancies complicated by red blood cell (RBC) and platelet alloimmunization, as well as handling severe hemolytic disease in fetuses and newborns. Dr. TOLY-NDOUR actively contributes to the development of new biological assays in the field of maternal, fetal, and neonatal hemobiology. She is also involved in various epidemiological studies focusing on maternal immunization and fetal/neonatal hemolytic disease. With numerous publications and presentations to her credit, Dr. TOLY-NDOUR’s expertise is widely recognized in the field of immunohematology and perinatal hemobiology.

Don’t miss this opportunity to gain valuable insights from Dr. Cécile TOLY-NDOUR. Sign up now for immediate access to this on-demand webinar and stay at the forefront of automated anti-D microtitration.

Sign up for immediate access to on‑demand webinar.

https://info.bio-rad.com/ww-IHD-transfusion-w4-registration-lp.html

Share it

Leave a Reply

Your email address will not be published. Required fields are marked *